Clinical Trial: A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: Pain
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of SBS-1000 Administered by Intraven
Brief Summary:
This study will be a single-center, double-blind, randomized placebo-controlled, adaptive, single ascending dose study.
Read more